Sonosensitive phase-changeable nanoparticle mediated enhanced chemotherapy in prostate cancer by low-intensity focused ultrasound

HIGHLIGHTS

  • who: Junyong Dai et al. from the Chongqing Key Laboratory of Molecular Imaging, Institute of Imaging, Department of Urology Surgery, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China have published the research: Sonosensitive Phase-Changeable Nanoparticle Mediated Enhanced Chemotherapy in Prostate Cancer by Low-Intensity Focused Ultrasound, in the Journal: (JOURNAL)
  • what: The authors report a sonosensitive nanoparticle modified with anti-PSMA (prostate-specific membrane antigen) were co-loaded with the chemotherapeutic agent docetaxel and the sonosensitizer IR780 as well as phase-changeable perfluorocarbon (PFC) liquids.
  • how: 2023 24 825 3 of 14 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?